Magnisense SE

https://www.magnisense.com

Magnisense is a privately held med-tech company that designs, develops, registers and markets rapid, mobile and connected diagnostic tests for heart diseases. After several years of research and development, the company is now reaching the market. These proprietary tests are based on MIAtek®, a technology that uses magnetic nanomaterials and is protected by worldwide patents. The tests fully meet the expectations of biologists and hospital doctors, allowing for quantitative and sensitive assays of cardiac markers in just 15 minutes and directly in whole blood, using a robust, portable and decentralized method at a competitive price. Magnisense was founded by the inventor of the technology, with a group of business angels, including Daniel Bernard and Jean-Patrick Voisin. The company's head office is based in Paris (France) and its laboratories are located on "Le Campus," in the heart of Lyon's Biopôle. *

	Start	2010-01-01 reorganised
	Group	Magnisense (Group)
	Predecessor	Magnisense SARL (LU)
	Industry	diagnostics (medical/biological)
	Industry 2	MIAtek® magnetic immunoassay technology
	Person	Santoro, Lyse (Magnisense 201511 CEO)

	Region	Paris
	Country	France
	Street	140 Rue du Faubourg Saint-Honoré
	City	75008 Paris
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]